EQRx, Inc. clinical trials

Acquired by Revolution Medicines, Inc., Nov 9, 2023 · source ↗

The registry lists 2 studies whose lead sponsor is EQRx, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 14, 2026.

Before and after it joined Revolution Medicines, Inc.

First submitted before EQRx, Inc. became part of Revolution Medicines, Inc.: 2
First submitted after EQRx, Inc. became part of Revolution Medicines, Inc.: 0
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Terminated: 1
Completed: 1

Phase

Phase 1: 1
Phase 2: 1

Where

United States: 2
Georgia: 1
Belgium: 1
Italy: 1
Mexico: 1
Moldova: 1

Registry sponsor names on this page

EQRx, Inc.2 studies

Something wrong with this grouping? Tell us on the Revolution Medicines, Inc. page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Revolution Medicines, Inc. studies →

A Study of Lerociclib in Participants With Advanced Breast CancerTerminatedNCT05085002Phase 2
Sponsor listed in the registry: EQRx, Inc. · First submitted before EQRx, Inc. became part of Revolution Medicines, Inc.
To Evaluate the Comparative Pharmacokinetics of Orally Administered EQ143 in Different Racial and Ethnic PopulationsCompletedNCT04969965Phase 1
Sponsor listed in the registry: EQRx, Inc. · First submitted before EQRx, Inc. became part of Revolution Medicines, Inc.